| Model Number |
ANTI-HAV II |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/08/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
There was an allegation of questionable elecsys anti-hav ii assay results for 1 patient sample on a cobas e 801 analytical unit.On (b)(6) 2022, the patient had anti-hav qualitative result of 0.008 c.O.I., interpreted as positive.On (b)(6) 2022 , the sample was re-centrifuged and repeated.The repeat anti-hav qualitative result was 0.00777 c.O.I., interpreted as positive.An anti-hav igm test was also performed on the sample and the result was 0.342 c.O.I., interpreted as negative.The sample was sent to another lab for elisa testing.The anti-hav igg and anti-hav igm results were both negative.It was confirmed that the patient had not recently received a hepatitis a vaccine.The positive anti-hav result was reported outside of the laboratory.The analyzer serial number is (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The calibration and qc data provided were acceptable.The investigation did not identify a product problem.The root cause of the event could not be determined.
|
| |
|
Additional Manufacturer Narrative
|
|
Patient samples were provided for investigation.The investigation was able to confirm the positive anti-hav result obtained at the customer site.Investigational thyroid testing was also performed which gave results indicating no interference with the anti-ru component of the reagent.The investigation is ongoing.
|
| |
|
Search Alerts/Recalls
|